Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Medina

Showing results (231-240 of 268) with videos related to

Pageof 27
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 15, 2017
Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled TrialDae Hyun Yoo, Chang-Hee Suh, Seung Cheol Shim, et al.
Viruses|September 28, 2021
Neonatal Development in Prenatally Zika Virus-Exposed Infant Macaques with Dengue ImmunityKarla Ausderau, Sabrina Kabakov, Elaina Razo, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 6, 2019
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III TrialChang-Hee Suh, Dae Hyun Yoo, Alfredo Berrocal Kasay, et al.
Mabs|July 17, 2018
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trialWon Park, Ljubinka Božić-Majstorović, Dragana Milakovic, et al.
Revista Argentina De Microbiologia|November 22, 2017
Molecular epidemiology and phylogenetic analysis of human papillomavirus infection in women with cervical lesions and cancer from the coastal region of EcuadorCesar H Bedoya-Pilozo, Lex G Medina Magües, Maylen Espinosa-García, et al.
Frontiers in Genetics|January 20, 2022
Imputation Performance in Latin American Populations: Improving Rare Variants Representation With the Inclusion of Native American GenomesAndrés Jiménez-Kaufmann, Amanda Y Chong, Adrián Cortés, et al.
Plos One|August 25, 2020
Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early β-cell damage in obesity and diabetesNelly F Altamirano-Bustamante, Eulalia Garrido-Magaña, Eugenia Morán, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Diagnosis of precocious puberty: clinical guideline for the diagnosis and treatment of precocious pubertyAmérica L Miranda-Lora, Margarita Torres-Tamayo, Jessie N Zurita-Cruz, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Methodology for the development of the Clinical guideline for the diagnosis and treatment of precocious pubertyMargarita Torres-Tamayo, Jessie N Zurita-Cruz, Blanca E Aguilar-Herrera, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Adjuvant interventions in the treatment of precocious puberty: Clinical guideline for the diagnosis and treatment of precocious pubertyMargarita Torres-Tamayo, Jessie N Zurita-Cruz, Blanca E Aguilar-Herrera, et al.
Pageof 27

Showing results (231-240 of 268) with videos related to

Sort By:
Pageof 27
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 15, 2017
Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled TrialDae Hyun Yoo, Chang-Hee Suh, Seung Cheol Shim, et al.
Viruses|September 28, 2021
Neonatal Development in Prenatally Zika Virus-Exposed Infant Macaques with Dengue ImmunityKarla Ausderau, Sabrina Kabakov, Elaina Razo, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 6, 2019
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III TrialChang-Hee Suh, Dae Hyun Yoo, Alfredo Berrocal Kasay, et al.
Mabs|July 17, 2018
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trialWon Park, Ljubinka Božić-Majstorović, Dragana Milakovic, et al.
Revista Argentina De Microbiologia|November 22, 2017
Molecular epidemiology and phylogenetic analysis of human papillomavirus infection in women with cervical lesions and cancer from the coastal region of EcuadorCesar H Bedoya-Pilozo, Lex G Medina Magües, Maylen Espinosa-García, et al.
Frontiers in Genetics|January 20, 2022
Imputation Performance in Latin American Populations: Improving Rare Variants Representation With the Inclusion of Native American GenomesAndrés Jiménez-Kaufmann, Amanda Y Chong, Adrián Cortés, et al.
Plos One|August 25, 2020
Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early β-cell damage in obesity and diabetesNelly F Altamirano-Bustamante, Eulalia Garrido-Magaña, Eugenia Morán, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Diagnosis of precocious puberty: clinical guideline for the diagnosis and treatment of precocious pubertyAmérica L Miranda-Lora, Margarita Torres-Tamayo, Jessie N Zurita-Cruz, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Methodology for the development of the Clinical guideline for the diagnosis and treatment of precocious pubertyMargarita Torres-Tamayo, Jessie N Zurita-Cruz, Blanca E Aguilar-Herrera, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Adjuvant interventions in the treatment of precocious puberty: Clinical guideline for the diagnosis and treatment of precocious pubertyMargarita Torres-Tamayo, Jessie N Zurita-Cruz, Blanca E Aguilar-Herrera, et al.
Pageof 27